Increased levels of pulmonary vasoconstrictive mediators including endothelin-1 and decreased expression of endothelial nitric oxide synthase and prostacyclin synthase have also been observed in COPD compared to normal patients [12,13,14,15]. This evidence concerns the gene PTGIS and chronic obstructive pulmonary disease.